Guangdong Hybribio Biotech Co.Ltd(300639) disclosure annual report. In 2021, the company realized an operating revenue of 267302295356 yuan, a year-on-year increase of 97.34%; The net profit attributable to the listed shareholders increased by 216019715% year on year; The basic earnings per share is 2.91 yuan / share. The company’s profit distribution plan for 2021 is to distribute cash dividend of 3.50 yuan (including tax) to all shareholders for every 10 shares, and increase 5 shares for every 10 shares to all shareholders with capital reserve.